Silicon Valley Computational Drug Startup Takes on Glaucoma
by from IEEE Spectrum on (#2FQCN)
Palo Alto startup twoXAR partners with Santen Pharmaceutical to identify new glaucoma drugs; efforts on rare skin disease, liver cancer, atherosclerosis, and diabetic nephropathy also underway